More from the article ...

... Private equity transactions are difficult to regulate and often not reviewed by antitrust authorities, as they tend to be below the federal mandatory reporting threshold (Federal Trade Commission A, 2020). More than 90% of PE-related takeovers or investments are not reviewed as there is little regulation of PE investment (Schulte, 2022). The acquisitions that are reviewed can still have widespread impacts on health care markets. ...

@#1

So, private equity seems to have found a very profitable area, with low regulation.

An area, health-care for profit, where it seems to prioritize profits over patients?